Skip to content

Clinical trials

Tuberculosis, Pulmonary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis, Pulmonary Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20082
20091
20101
20111
20121
20151
20172
20181
20191
20201
20211
20223
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting2
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Global Alliance for TB Drug Development7
National Institute of Allergy and Infectious Diseases (NIAID)5
Centers for Disease Control and Prevention4
Access to Advanced Health Institute (AAHI)2
Andrew Dinardo1
Boston Medical Center1
Children's Hospital Medical Center, Cincinnati1
Johns Hopkins University1
Landon Pediatric Foundation1
NYU Langone Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis, Pulmonary26
Tuberculosis17
AIDS-Related Opportunistic Infections3
Acquired Immunodeficiency Syndrome3
HIV Infections3
Tuberculosis, Multidrug-Resistant3
Extensively Drug-Resistant Tuberculosis2
Lung Diseases2
Helminthiasis1
Latent Tuberculosis1

Trials

Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.